INTERNATIONAL PATENT: FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR), FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA (IRB) FILES APPLICATION FOR "AN ANTIBODY-BASED STRATEGY TARGETING ACTIVATED ONCOGENIC ERG IN PROSTATE CANCER"

GENEVA, June 16 -- FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) (Via Francesco Chiesa 56500 Bellinzona), FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA (IRB) (Via Francesco Chiesa 56500 Bellinzona) filed a patent application (PCT/IB2024/061789) for "AN ANTIBODY-BASED STRATEGY TARGETING ACTIVATED ONCOGENIC ERG IN PROSTATE CANCER" on Nov 25, 2024. With publication no. WO/2025/120444, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CATAPANO, Carlo (c/o Fondazione per l'Istituto Oncologico di Ricerca (IOR)Via Fr...